Home › Funds › Citigroup Inc › NRIX
Citigroup Inc position in NRIX
NURIX THERAPEUTICS INC · Health Care
Latest position (Q2 2026)389.38K sh
Reported value held$9.45M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 120.65K | $3.62M | New |
| Q4 2021 | 76.61K | $2.22M | Reduce |
| Q1 2022 | 25.18K | $353.00K | Reduce |
| Q2 2022 | 75.27K | $954.00K | Add |
| Q3 2022 | 120.52K | $1.57M | Add |
| Q4 2022 | 73.60K | $808.08K | Reduce |
| Q1 2023 | 113.10K | $1.00M | Add |
| Q2 2023 | 46.96K | $469.13K | Reduce |
| Q3 2023 | 42.20K | $331.69K | Reduce |
| Q4 2023 | 15.14K | $156.30K | Reduce |
| Q1 2024 | 184.78K | $2.72M | Add |
| Q2 2024 | 27.42K | $572.30K | Reduce |
| Q3 2024 | 49.59K | $1.11M | Add |
| Q4 2024 | 107.35K | $2.02M | Add |
| Q1 2025 | 140.47K | $1.67M | Add |
| Q2 2025 | 43.73K | $498.05K | Reduce |
| Q3 2025 | 7.37K | $68.07K | Reduce |
| Q4 2025 | 171.10K | $3.25M | Add |
| Q1 2026 | 477.41K | $7.40M | Add |
| Q2 2026 | 389.38K | $9.45M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NRIX
- BlackRock Inc 8.77M sh · $212.77M · Q2 2026
- Fidelity Management & Research (FMR) 5.49M sh · $133.07M · Q2 2026
- Morgan Stanley 4.76M sh · $115.54M · Q2 2026
- Vanguard Group 5.95M sh · $112.86M · Q4 2025
- Geode Capital Management 2.54M sh · $61.57M · Q2 2026
- ARK Invest 1.79M sh · $43.50M · Q2 2026
- Capital World Investors 1.79M sh · $43.37M · Q2 2026
- Citadel Advisors 1.53M sh · $37.10M · Q2 2026
- UBS Group AG 917.12K sh · $22.25M · Q2 2026
- Northern Trust Corp 876.07K sh · $21.25M · Q2 2026
- Bank of America Corp 842.09K sh · $20.43M · Q2 2026
- Charles Schwab Investment Management 833.30K sh · $20.22M · Q2 2026